Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | T. S. Crocenzi, A. B. El-Khoueiry, T. C. Yau, I. Melero, B. Sangro, M. Kudo, C. Hsu, J. Trojan, T. Kim, S. Choo, T. Meyer, Y. Kang, W. Yeo, A. Chopra, A. Baakili, C. M. Dela Cruz, L. Lang, J. Neely, T. Welling | ||||||||||||
Title | Nivolumab (nivo) in sorafenib (sor)-naive and -experienced pts with advanced hepatocellular carcinoma (HCC): CheckMate 040 study. | ||||||||||||
|
|||||||||||||
URL | http://meetinglibrary.asco.org/record/152902/abstract | ||||||||||||
Abstract Text | J Clin Oncol 35, 2017 (suppl; abstr 4013) |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|